Obstructive sleep apnea – disruptive snoring – is linked to conditions such as high blood pressure and heart disease and other hazards to your health. Learn more from WebMD. Pillows that put ...

Most of these products won't be a permanent treatment for moderate to severe sleep apnea, but continuous positive airway pressure machines are still the gold standard for sleep apnea treatment.

The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

In the trial that Lilly, the drug's manufacturer, submitted in April to the FDA, scientists reported that the drug helped people who were overweight or obese with sleep apnea reduce a standard ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

Tired of snoring and restless nights? Sound Sleep Medical, with 25+ years of expertise, offers premium care for sleep apnea ...

Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease. The sleep disorder also appears to have direct effects on brain health, a new study ...

"Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," said Sally ...

Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea syndrome (OSAS) per se, although only some patients ...

GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea By India Edwards HealthDay Reporter MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the ...

Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.